On the other hand, a dysregulated brain insulin signaling, defined as “brain insulin resistance”, has been proposed among factors responsible for AD progression [19], and the impaired activity of several mediators in the insulin-signaling pathways may contribute to neurodegeneration and AD symptoms [51,52]. Here, INS is linked to Alzheimer disease.